The FDA granted Cardiac Dimensions an investigation device exemption for the company to begin a pivotal trial evaluating the Carillon mitral contour system to treat symptomatic functional mitral regurgitation associated with heart failure.

The Centers for Medicare and Medicaid Services (CMS) recently announced that three facilities had met its standards for destination therapy with ventricular assist devices.

Since 2005, the mortality from myocarditis has decreased, although it remains a difficult disease to treat and diagnose, according to a recent review.

A pooled analysis of four cohort studies found that patients who did not have hypertension, obesity and diabetes by 45 to 55 years old had up to an 86 percent lower risk of developing heart failure during their lifetime.

Genetics isn’t the only determinant of heart disease. Healthy habits can decrease the risk of developing issues later in life. 

A registry analysis found that the quality of care and one-year clinical outcomes for Medicare beneficiaries were similar at centers with low and high risk-adjusted 30-day heart failure readmission rates.

A new study finds that a single bout of sleep apnea deteriorates the circulatory system. 

After one year, the HeartLogic heart failure diagnostic service helped alert healthcare professionals of worsening heart failure in patients with cardiac resynchronization therapy defibrillator (CRT-D) systems, according to a multicenter, nonrandomized trial.